Blog

‘Health benefits of UK’s sugar tax will depend on industry’: Lancet study – FoodNavigator.com

Posted: Tuesday, December 20, 2016

The impact on public health of the UK’s sugar tax will depend on industry’s response to it, according to the authors of a Lancet study. If firms choose to cut the sugar content of soft drinks, the biggest beneficiaries will be children, they write.  The scientists estimated the impact on rates of obesity, type 2 diabetes and tooth decay according to best and worst-case scenarios of three potential industry responses:…

‘Health benefits of UK’s sugar tax will depend on industry’: Lancet study – FoodNavigator.com

Posted: Monday, December 19, 2016

The impact on public health of the UK’s sugar tax will depend on industry’s response to it, according to the authors of a Lancet study. If firms choose to cut the sugar content of soft drinks, the biggest beneficiaries will be children, they write.  The scientists estimated the impact on rates of obesity, type 2 diabetes and tooth decay according to best and worst-case scenarios of three potential industry responses:…

‘Health benefits of UK’s sugar tax will depend on industry’: Lancet study – FoodNavigator.com

Posted: Monday, December 19, 2016

The impact on public health of the UK’s sugar tax will depend on industry’s response to it, according to the authors of a Lancet study. If firms choose to cut the sugar content of soft drinks, the biggest beneficiaries will be children, they write.  The scientists estimated the impact on rates of obesity, type 2 diabetes and tooth decay according to best and worst-case scenarios of three potential industry responses:…

The Lancet publishes FITZROY study results with filgotinib in Crohn’s disease – Yahoo Finance

Posted: Monday, December 19, 2016

Mechelen, Belgium; 12 December 2016 – Galapagos NV (Euronext & NASDAQ: GLPG) reports publication of the Phase 2 study with filgotinib in Crohn’s disease in The Lancet. “Filgotinib, a selective JAK1 inhibitor, induces clinical remission in patients with moderate-to-severe Crohn’s disease: results from the phase II double-blind, randomized, placebo-controlled FITZROY study,” by Dr Severine Vermeire et al. describes the study design and full results and can be found online at…

‘Health benefits of UK’s sugar tax will depend on industry’: Lancet study – FoodNavigator.com

Posted: Monday, December 19, 2016

The impact on public health of the UK’s sugar tax will depend on industry’s response to it, according to the authors of a Lancet study. If firms choose to cut the sugar content of soft drinks, the biggest beneficiaries will be children, they write.  The scientists estimated the impact on rates of obesity, type 2 diabetes and tooth decay according to best and worst-case scenarios of three potential industry responses:…

‘Health benefits of UK’s sugar tax will depend on industry’: Lancet study – FoodNavigator.com

Posted: Monday, December 19, 2016

The impact on public health of the UK’s sugar tax will depend on industry’s response to it, according to the authors of a Lancet study. If firms choose to cut the sugar content of soft drinks, the biggest beneficiaries will be children, they write.  The scientists estimated the impact on rates of obesity, type 2 diabetes and tooth decay according to best and worst-case scenarios of three potential industry responses:…

Delhi’s mohalla clinics proving popular with residents: Lancet – Times of India

Posted: Monday, December 19, 2016

City More HomeHome City Delhi Citizen Reporter Crime Civic Issues Politics Schools & Colleges Events ALL PTI | Updated: Dec 11, 2016, 06.45 PM IST Highlights Delhi’s ‘mohalla clinics’ scheme is proving “popular” with residents, according to The Lancet journal. The mohalla clinics opened as part of a flagship programme by the AAP government launched in July last year. Although mohalla clinics have added another layer to the existing system,…

‘Health benefits of UK’s sugar tax will depend on industry’: Lancet study – FoodNavigator.com

Posted: Sunday, December 18, 2016

The impact on public health of the UK’s sugar tax will depend on industry’s response to it, according to the authors of a Lancet study. If firms choose to cut the sugar content of soft drinks, the biggest beneficiaries will be children, they write.  The scientists estimated the impact on rates of obesity, type 2 diabetes and tooth decay according to best and worst-case scenarios of three potential industry responses:…

The Lancet publishes FITZROY study results with filgotinib in Crohn’s disease – Yahoo Finance

Posted: Sunday, December 18, 2016

Mechelen, Belgium; 12 December 2016 – Galapagos NV (Euronext & NASDAQ: GLPG) reports publication of the Phase 2 study with filgotinib in Crohn’s disease in The Lancet. “Filgotinib, a selective JAK1 inhibitor, induces clinical remission in patients with moderate-to-severe Crohn’s disease: results from the phase II double-blind, randomized, placebo-controlled FITZROY study,” by Dr Severine Vermeire et al. describes the study design and full results and can be found online at…

‘Health benefits of UK’s sugar tax will depend on industry’: Lancet study – FoodNavigator.com

Posted: Sunday, December 18, 2016

The impact on public health of the UK’s sugar tax will depend on industry’s response to it, according to the authors of a Lancet study. If firms choose to cut the sugar content of soft drinks, the biggest beneficiaries will be children, they write.  The scientists estimated the impact on rates of obesity, type 2 diabetes and tooth decay according to best and worst-case scenarios of three potential industry responses:…

The Lancet publishes FITZROY study results with filgotinib in Crohn’s disease – Yahoo Finance

Posted: Sunday, December 18, 2016

Mechelen, Belgium; 12 December 2016 – Galapagos NV (Euronext & NASDAQ: GLPG) reports publication of the Phase 2 study with filgotinib in Crohn’s disease in The Lancet. “Filgotinib, a selective JAK1 inhibitor, induces clinical remission in patients with moderate-to-severe Crohn’s disease: results from the phase II double-blind, randomized, placebo-controlled FITZROY study,” by Dr Severine Vermeire et al. describes the study design and full results and can be found online at…

‘Health benefits of UK’s sugar tax will depend on industry’: Lancet study – FoodNavigator.com

Posted: Sunday, December 18, 2016

The impact on public health of the UK’s sugar tax will depend on industry’s response to it, according to the authors of a Lancet study. If firms choose to cut the sugar content of soft drinks, the biggest beneficiaries will be children, they write.  The scientists estimated the impact on rates of obesity, type 2 diabetes and tooth decay according to best and worst-case scenarios of three potential industry responses:…

Delhi’s mohalla clinics proving popular with residents: Lancet – Times of India

Posted: Sunday, December 18, 2016

City More HomeHome City Delhi Citizen Reporter Crime Civic Issues Politics Schools & Colleges Events ALL PTI | Updated: Dec 11, 2016, 06.45 PM IST Highlights Delhi’s ‘mohalla clinics’ scheme is proving “popular” with residents, according to The Lancet journal. The mohalla clinics opened as part of a flagship programme by the AAP government launched in July last year. Although mohalla clinics have added another layer to the existing system,…

‘Health benefits of UK’s sugar tax will depend on industry’: Lancet study – FoodNavigator.com

Posted: Sunday, December 18, 2016

The impact on public health of the UK’s sugar tax will depend on industry’s response to it, according to the authors of a Lancet study. If firms choose to cut the sugar content of soft drinks, the biggest beneficiaries will be children, they write.  The scientists estimated the impact on rates of obesity, type 2 diabetes and tooth decay according to best and worst-case scenarios of three potential industry responses:…

Delhi’s mohalla clinics proving popular with residents: Lancet – Times of India

Posted: Sunday, December 18, 2016

City More HomeHome City Delhi Citizen Reporter Crime Civic Issues Politics Schools & Colleges Events ALL PTI | Updated: Dec 11, 2016, 06.45 PM IST Highlights Delhi’s ‘mohalla clinics’ scheme is proving “popular” with residents, according to The Lancet journal. The mohalla clinics opened as part of a flagship programme by the AAP government launched in July last year. Although mohalla clinics have added another layer to the existing system,…

‘Health benefits of UK’s sugar tax will depend on industry’: Lancet study – FoodNavigator.com

Posted: Sunday, December 18, 2016

The impact on public health of the UK’s sugar tax will depend on industry’s response to it, according to the authors of a Lancet study. If firms choose to cut the sugar content of soft drinks, the biggest beneficiaries will be children, they write.  The scientists estimated the impact on rates of obesity, type 2 diabetes and tooth decay according to best and worst-case scenarios of three potential industry responses:…

Delhi’s mohalla clinics proving popular with residents: Lancet – Times of India

Posted: Sunday, December 18, 2016

City More HomeHome City Delhi Citizen Reporter Crime Civic Issues Politics Schools & Colleges Events ALL PTI | Updated: Dec 11, 2016, 06.45 PM IST Highlights Delhi’s ‘mohalla clinics’ scheme is proving “popular” with residents, according to The Lancet journal. The mohalla clinics opened as part of a flagship programme by the AAP government launched in July last year. Although mohalla clinics have added another layer to the existing system,…

The Lancet publishes FITZROY study results with filgotinib in Crohn’s disease – Yahoo Finance

Posted: Saturday, December 17, 2016

Mechelen, Belgium; 12 December 2016 – Galapagos NV (Euronext & NASDAQ: GLPG) reports publication of the Phase 2 study with filgotinib in Crohn’s disease in The Lancet. “Filgotinib, a selective JAK1 inhibitor, induces clinical remission in patients with moderate-to-severe Crohn’s disease: results from the phase II double-blind, randomized, placebo-controlled FITZROY study,” by Dr Severine Vermeire et al. describes the study design and full results and can be found online at…

The Lancet publishes FITZROY study results with filgotinib in Crohn’s disease – Yahoo Finance

Posted: Saturday, December 17, 2016

Mechelen, Belgium; 12 December 2016 – Galapagos NV (Euronext & NASDAQ: GLPG) reports publication of the Phase 2 study with filgotinib in Crohn’s disease in The Lancet. “Filgotinib, a selective JAK1 inhibitor, induces clinical remission in patients with moderate-to-severe Crohn’s disease: results from the phase II double-blind, randomized, placebo-controlled FITZROY study,” by Dr Severine Vermeire et al. describes the study design and full results and can be found online at…

‘Health benefits of UK’s sugar tax will depend on industry’: Lancet study – FoodNavigator.com

Posted: Saturday, December 17, 2016

The impact on public health of the UK’s sugar tax will depend on industry’s response to it, according to the authors of a Lancet study. If firms choose to cut the sugar content of soft drinks, the biggest beneficiaries will be children, they write.  The scientists estimated the impact on rates of obesity, type 2 diabetes and tooth decay according to best and worst-case scenarios of three potential industry responses:…